CDSCO Panel Rejects Phase III Waiver Plea for Prucalopride Over Safety Data Gaps

FDA approves Zoryve cream 0.05% for pediatric atopic dermatitis

DRRA1 hour ago 0

Evolocumab made available via direct-to-patient program

DRRA1 hour ago 0

Maintaining CV health early key to CVD prevention later in life

DRRA1 hour ago 0

Smoking decline leads to fewer newborns with gastroschisis, research finds

DRRA2 hours ago 0